Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC provides support with reimbursement applications in the Nordic region and Russia

The ultimate step in establishing reimbursement is achieved by making reimbursement applications to authorities.

In the DRG-based countries, it includes the creation of a specific procedure code and a subsequent application for the creation of a new DRG or making re-grouping of the procedure in scope to another existing DRG. The creation of an appropriate DRG tariff helps to secure sufficient reimbursement and funding to hospitals and supports the adoption of novel medical technologies.

Reimbursement applications are made by clinical societies or physicians (hospital administrators). But the development of the application takes time, often requires specialized expertise and coordination with data collection between several clinics. Physicians and key opinion leaders often do not have time to develop a proper application.

MTRC provides support with the development of draft reimbursement applications in two important geographical regions in Europe, which lacks good local Med Tech consultancies, the Nordic region, and Russia.

Learn more here